title: Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning.
authors.forename: T
authors.initials: T
authors.lastname: Prébet
authors.forename: R
authors.initials: R
authors.lastname: Devillier
authors.forename: S
authors.initials: S
authors.lastname: Fürst
authors.forename: N
authors.initials: N
authors.lastname: Vey
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D002872:Chromosome Deletion; D002897:Chromosomes, Human, Pair 7; D017809:Fatal Outcome; D005260:Female; D006338:Heart Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D006350:Heart Valve Prosthesis; D006648:Histocompatibility; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000150:complications; D010198:Pancytopenia / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D012509:Sarcoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D019172:Transplantation Conditioning / Q000379:methods*